Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kitchen Prescription Foods May Not Make Structure/Function Claims - FDA

This article was originally published in The Tan Sheet

Executive Summary

Hain Food Group soups marketed under the Kitchen Prescription brand name and containing St. John's wort or echinacea are conventional foods, not dietary supplements, and therefore may not bear structure/function claims, FDA states in a July 19 "courtesy" letter. The letter is similar to that sent to McNeil for its Benecol margarine. The firm subsequently decided to market the product as a conventional food (1"The Tan Sheet" Feb. 1, p. 4).

You may also be interested in...



FDA Strategy For Functional Food Safety And Claims Needed, CSPI Urges

FDA should take action to ensure "functional food" products are safe and bear truthful labeling claims, the Center for Science in the Public Interest asserts in a March 25 letter to FDA Commissioner Jane Henney, MD, and in an accompanying report entitled "Functional Foods - Public Health Boon or 21st Century Quackery."

McNeil Commits To Benecol Marketing As Conventional Food

McNeil Consumer Healthcare's Benecol margarine with cholesterol-lowering stanol ester could be on the market this spring following the company's decision to market the product as a food instead of as a dietary supplement.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090169

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel